Garfield Township, Michigan - February 25, 2026 - PRESSADVANTAGE - Stephen Twomey has published a new educational ...
NEWARK, CA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ended ...
NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results